Mitochondrial disfunction in Parkinson's disease
Authors:
- 1 May 2011
- journal article
- abstracts
- Published by Institute of Biochemistry in Biomeditsinskaya Khimiya
- Vol. 57 (3) , 246-281
Abstract
Mitochondrial structural and functional abnormalities in Parkinson's disease and experimental animal models of this pathology are described. Special attention is paid to the inactivation of mitochondrial enzymes, mutations in mitochondrial and nuclear DNA, and genomic and proteomic research of mitochondrial proteins in Parkinson's disease and experimental parkinsonism of animals.Keywords
This publication has 229 references indexed in Scilit:
- Phactr2 and Parkinson's diseaseNeuroscience Letters, 2009
- Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's diseaseNeuroscience Letters, 2008
- The Parkinson’s disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase thatstimulates kinase activityExperimental Cell Research, 2007
- The R1441C mutation of LRRK2 disrupts GTP hydrolysisBiochemical and Biophysical Research Communications, 2007
- Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis?Neuroscience Letters, 2004
- Analysis of European mitochondrial haplogroups with Alzheimer disease riskNeuroscience Letters, 2004
- Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's diseaseAnnals of Neurology, 2004
- Phosphorylation of α-synuclein characteristic of synucleinopathy lesions is recapitulated in α-synuclein transgenic DrosophilaNeuroscience Letters, 2003
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000
- Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's diseaseBiochemical and Biophysical Research Communications, 1991